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MEDICAL IMAGING
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Abstract

Modus Medical Devices Inc., London, ON,
Canada

MR‐only treatment planning and MR‐IGRT leverage MRI's powerful soft tissue con-
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phantoms are currently limited. This work describes the development and evaluation
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ject data were assessed for phantom/skeletal geometry and internal organ kinematics

trast for high‐precision radiation therapy. However, anthropomorphic MR‐compatible
of a custom‐designed, modular, pelvic end‐to‐end (PETE) MR‐compatible phantom to
benchmark MR‐only and MR‐IGRT workﬂows. For construction considerations, subto simulate average male pelvis anatomy. Various materials for the bone, bladder, and
rectum were evaluated for utility within the phantom. Once constructed, PETE underwent CT‐SIM, MR‐Linac, and MR‐SIM imaging to qualitatively assess organ visibility.
Scans were acquired with various bladder and rectal volumes to assess component
interactions, ﬁlling capabilities, and ﬁlling reproducibility via volume and centroid differences. PETE simulates average male pelvis anatomy and comprises an acrylic body
oval (height/width = 23.0/38.1 cm) and a cast‐mold urethane skeleton, with silicone
balloons simulating bladder and rectum, a silicone sponge prostate, and hydrophilic
poly(vinyl alcohol) foam to simulate fat/tissue separation between organs. Access ports
enable retroﬁtting the phantom with other inserts including point/ﬁlm‐based dosimetry
options. Acceptable contrast was achievable in CT‐SIM and MR‐Linac images. However, the bladder was challenging to distinguish from background in CT-SIM. The
desired contrast for T1‐weighted and T2‐weighted MR‐SIM (dark and bright bladders,
respectively) was achieved. Rectum and bone exhibited no MR signal. Inputted volumes differed by <5 and <10 mL from delineated rectum (CT‐SIM) and bladder (MR‐
SIM) volumes. Increasing bladder and rectal volumes induced organ displacements and
shape variations. Reproduced volumes differed by <4.5 mL, with centroid displacements <1.4 mm. A point dose measurement with an MR‐compatible ion chamber in an
MR‐Linac was within 1.5% of expected. A novel, modular phantom was developed
with suitable materials and properties that accurately and reproducibly simulate status
changes with multiple dosimetry options. Future work includes integrating more realistic organ models to further expand phantom options.
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1 | INTRODUCTION

treatment scenarios in MR‐IGRT15 with the ability to induce volume
variations in both the bladder and rectum. However, sodium salt‐

Radiation therapy (RT) treatments are traditionally planned using

loaded gels used to mimic soft tissue attenuation properties induced

computed‐tomography simulation (CT‐SIM) images, with interfraction

severe MR artifacts. In general, these phantoms met their individual

patient setup veriﬁcation performed using x‐ray‐based on‐board (OB)

design goals but lacked the ability to perform dosimetric veriﬁcation

imaging techniques. Although CT offers strengths such as providing

as required to benchmark MR‐IGRT or MR‐only workﬂows.

a direct measurement of electron density for dose calculation and

This work describes the development of a novel pelvic end‐to‐

geometric image accuracy, it lacks the excellent soft tissue contrast

end (PETE) MR‐compatible phantom that meets the design goals of

achievable from magnetic resonance imaging (MRI).1 In the male pel-

benchmarking both MR‐only treatment planning and MR‐IGRT

vis, MRI has been shown to improve prostate delineation accuracy,2–

workﬂows. The phantom is anthropomorphic and modular and

5

reduce interobserver contouring variability,3–6 improve the localiza-

enables dosimetric validation. Furthermore, the phantom can simu-

tion of the prostate apex,2–6 and increase differentiation of the semi-

late different physiological status conditions and may be used to

nal vesicles from the base of the prostate.2,4,6 Consequently,

quantify the uncertainties introduced in both MR‐only and MR‐

treatment planning using MR/CT coregistered images, where delin-

IGRT workﬂows.

eated soft tissue structures on MR images are transferred onto fused
CT images, is often utilized.2,6 However, uncertainties on the order
of 2 mm are introduced due to this coregistration in the pelvis7,8
that may be reduced with MR‐only radiation treatment planning.9
MR‐only treatment planning eliminates this coregistration uncer-

2 | MATERIALS AND METHODS
2.A | Phantom geometry
Phantom outer dimensions were determined via retrospective evalu-

tainty while streamlining clinical efﬁciency.
Furthermore, the implementation of on‐board MR image‐guided

ation of axial MR‐SIM T2‐weighted (T2W) Turbo‐Spin‐Echo (TSE)

radiation therapy (IGRT) systems allows for daily image guidance and

data for 19 prostate cancer patients under an IRB‐approved study.

real‐time imaging throughout a treatment fraction, which is ideal for

Patients were positioned supine and head‐ﬁrst, aligned using external

managing and monitoring both interfraction and intrafraction motion,

LAP lasers (LAP GmbH Laser Applications, Lüneberg, Germany) to

10,11

It has been

right central axis (CAX), left CAX, and anterior CAX tattoos. They

shown that critical structures and targets within the pelvis are better

were immobilized with their hands placed on chest, feet banded, and

visualized on MR‐IGRT systems than OB‐CT,10 allowing for superior

knees immobilized in a black leg sponge. The phantom habitus was

target localization. This, in turn, may lead to improved accuracy of

determined by evaluating data taken in treatment position at the

MR‐to‐MR registration and facilitate dose escalation while also offer-

marked isocenter across the cohort. Measurements of the pelvis

ing potential to reduce treatment margins and toxicity to organs at

width, pelvis height, and sacrum external spacing (distance between

risk.11

the posterior edge of the sacrum and the exterior body surface)

respectively, without additional radiation exposure.

However, MRI and MR simulation (MR‐SIM) acquisitions typically

were taken using the distance measurement tool in the Eclipse

require longer scanning times than CT, which may result in additional

Treatment Planning System (Varian Medical Systems, Palo Alto, CA).

errors being introduced because of anatomical or patient move-

Because of the high visibility of the pelvic bones in the CT‐SIM data-

ment.12 In the pelvis, multiple uncertainties may arise as a result of

set, the pelvic skeleton dimensions across the same 19 subjects were

patient motion, changes in anatomical structure (position/deforma-

also determined using the treatment planning CT for each patient.

tion) due to intrasession bladder ﬁlling, and the introduction of

Measurements for the iliac crest width, femoral head width, greater

13

patient‐speciﬁc distortions due to air in the rectum.

Because of

this transient nature, it is currently difﬁcult to characterize the geo-

trochanter width, pelvic skeleton depth, and pelvic skeleton height
were also obtained using the distance measurement tool in Eclipse.

metric and dosimetric uncertainties that may arise in these new
workﬂows. MR‐compatible phantoms are currently limited for benchmarking these new workﬂows. Recently, an anthropomorphic multi-

2.B | Internal organ kinematics

modality prostate phantom was developed to compare MR‐SIM to

To quantify the impact of systematic bladder ﬁlling on organ volume,

CT‐SIM.14 The phantom was custom designed with organs (prostate,

location, and displacement, 10 immobilized healthy volunteers under-

rectum, bladder, and femoral heads) that adequately generated signal

went a ~45‐min MR‐SIM imaging session using the bladder ﬁlling

in MR for end‐to‐end testing. However, it was unable to simulate

protocol outlined in Fig. 1. Subjects voided their bladder prior to

organ ﬁlling. Niebuhr et al. performed a thorough material evaluation

consuming 600 mL of water, T2W sequences were acquired immedi-

to create a deformable male pelvic phantom to study adaptive

ately with empty bladders and ~15 min postconsumption with
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partially full bladders. An additional 300–600 mL of water were con-

imaged in a 1.0‐T Panorama High‐Field Open (HFO) system (Philips

sumed with no subject repositioning, and one to two more time

Medical Systems, Best, the Netherlands). The general shape, long‐

points were acquired with full bladders. A single physician delineated

term stability, and ﬁlling capacity of each of these balloon assemblies

the bladder and rectum at each time point following RTOG 0815 cri-

were assessed. To evaluate the potential of ﬁlling the silicone bal-

teria.16 Temporal datasets were evaluated for the center of mass,

loon to >300 mL, the ﬁlling integrity was assessed by ﬁlling it

shape, and volume of the rectum and bladder with varied ﬁlling con-

repeatedly to 500 mL and visually inspecting the balloon for

ditions. To characterize the rectum shape, measurements were

mechanical/physical changes.

obtained as shown in Fig. 2(a) for the width of the anterior, posterior, and middle of the rectum, the length, and the distance from the
coccyx to the posterior of the rectum.

2.C.2 | Bone considerations
Two candidate custom pelvic skeletons produced by Stratasys

2.C | Phantom materials
2.C.1 | Bladder considerations
Two medical balloon catheter assemblies, a 600‐mL maximum inter-

(Stratasys Ltd., Eden Prairie, MN) were custom cast in WC‐788
(clear) and PT8957 (blue) urethane material using average male pelvic geometry, with densities of 1.10 and 1.25 g/mL, respectively.
Both pelvises underwent imaging in a Brilliance Big Bore (Philips

nal volume polyisoprene balloon (#CBL7P, Mui Scientiﬁc) and a 300‐

Health Care, Cleveland, OH) CT‐SIM and a Philips 1.0‐T High‐Field

mL maximum internal volume silicone balloon (#BM‐300‐2, Mui Sci-

Open (HFO) MR‐SIM. Because cortical bone exhibits short T2 and

entiﬁc) were evaluated for preliminary material evaluation for simu-

T2* properties, it is typically undetectable in MRI. However,

lating bladder status changes. The polyisoprene balloon was ﬁlled

improved visibility is achieved through the utilization of ultra‐short

with distilled water using a 20‐mL syringe to increasing volumes up

echo time (UTE) sequences.17 Therefore, both pelvises were imaged

to 350 mL while the silicone balloon was ﬁlled to 250 mL and

using a UTE‐Dixon sequence (repetition time (TR)/echo time (TE)/ﬂip

F I G . 1 . Bladder ﬁlling protocol: the patient originally voided their bladder then consumed ~600 mL of water. A T2W MR‐SIM scan was
acquired immediately after drinking and 15 min later. After which, the subject consumed an additional 300–600 mL of water and was imaged
again a total of 30 min after the initial bladder void. A 3D modeling is shown for each time point, where a much larger longitudinal than lateral
growth of the bladder is observed.

F I G . 2 . Rectum dimension
measurements: (a) visually demonstrates
the growth and positioning of the bladder
throughout the bladder ﬁlling protocol. The
initial and ﬁnal bladder volumes are
contoured in blue and yellow, respectively,
while the initial and ﬁnal rectums are
contoured in green and brown,
respectively. The corresponding initial and
ﬁnal rectum measurements demonstrated
in (a) are shown in (b), where a larger
rectum length was observed than width.
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angle (α) = 11.5/(0.14/3.45/6.9) ms/25°, voxel size = 0.96 × 0.96 ×

volume changes were assessed for each contoured organ. Bladder

1.3 mm3, and bandwidth = 994 Hz/pixel) to determine if any mea-

and rectum diameters [left–right (L‐R) and anterior–posterior (A‐P)]
were measured with increased bladder and rectum ﬁlling to assess

surable signal was detected.

shape changes due to differing ﬁlling conditions. Associations

2.D | Phantom evaluation

between bladder and rectum volumes and resulting centroid displacements were assessed via linear regression.

2.D.1 | Scan acquisition
The ﬁnal phantom build was evaluated across three platforms. CT images
were acquired using a Philips Brilliance Big Bore CT‐SIM with the follow-

2.D.4 | Reproducibility tests

ing settings: 120 kVp, 244 mAs, 512 × 512 mm2 ﬁeld of view (FOV),

To assess the reproducibility of organ ﬁlling, repeated measures

0.98 × 0.98 mm2 resolution, and 2.0‐mm slice thickness. To ensure con-

were conducted for rectal volumes of 30 and 60 mL for the CT‐SIM

sistent positioning within each imaging modality, the phantom was

and MR‐linac with a ﬁxed bladder volume of 250 mL. Repeated mea-

aligned via external LAP lasers to the external markings (anterior CAX,

sures of rectal and bladder volumes of 30 and 250 mL, respectively,

left CAX, and right CAX) made during CT‐SIM. MR images were acquired

were obtained in the MR‐SIM. Reproducibility was assessed by con-

on the MRIdian Linac (ViewRay Inc., Oakwood Village, OH) using a true

touring organs in MIM and analyzing the centroid and volume differ-

fast imaging and steady precession (TrueFISP) sequence. This is a fully

ences over repeated trials.

refocused (refocusing occurs in all three axes) steady‐state sequence with
shorter acquisition time, high contrast‐to‐noise, and signal‐to‐noise
ratios.18 Two 12‐element phased array coils were used for imaging the

2.E | Treatment plan and dosimetry veriﬁcation

phantom. A 173‐s scan, with a 45 × 30 × 36 cm3 FOV, and

A CT‐SIM was performed with bladder and rectum volumes of 250

0.15 × 0.15 cm resolution was acquired.

and 90 mL, respectively. Isocenter was set to the center of the sili-

2

The MR‐SIM images were acquired using the 1.0‐T MR‐SIM

cone sponge prostate. The bladder, rectum, and prostate, which

equipped with a ﬂat tabletop using a large, rigid eight‐element

were set as the gross tumor volume (GTV), were manually contoured

phased array coil. Three sequences were acquired: an axial three‐

in the ViewRay treatment planning system (TPS) (ViewRay Inc., Oak-

dimensional (3D) T1‐weighted (T1W) fast ﬁeld echo sequence (TR/

wood Village, OH). To ensure the chamber location was not in a

TE/α = 17.7/6.9 ms/25°, voxel size = 0.96 × 0.96 × 2.5 mm3, and

high‐dose gradient region, a 2.5‐cm margin in the posterior direction,

bandwidth = 145 Hz/pixel), an axial 3D T2W TSE sequence (TR/TE/

and 1.0‐cm margin in all other directions were added to the GTV to

α = 6591.4/80 ms/90°,

and

generate a pseudo-planning target volume (PTV). An 11‐ﬁeld IMRT

bandwidth = 202 Hz/pixel), and a sagittal T2W (TR/TE/α = 2000/

6X Flattening Filter Free (FFF) MR‐Linac treatment plan was gener-

90 ms/90°,

voxel

voxel

size = 0.92 × 0.92 × 2.5 mm3,

size = 0.89 × 0.89 × 3.0 mm3,

and

band-

width = 202 Hz/pixel).

ated on the CT dataset using a Monte Carlo dose calculation
algorithm based on VMC++8 in the ViewRay TPS. Fifty step‐and‐
shoot segments were used for a total MU of 756.5 and a target

2.D.2 | Simulating bladder and rectal status changes

dose constraint of 78 Gy to 95.00% of the PTV, delivered in
39 × 2 Gy fractions. After CT‐SIM, the phantom was setup to

Across all three imaging platforms, scans were acquired with a con-

scribes on the MR‐Linac, localized with a 173 s, 45 × 30 × 36 cm3

stant bladder volume of 250 mL and varying inputted rectal volumes

FOV, and 0.15 × 0.15 cm2 resolution TrueFISP MRI sequence.

(30, 60, 90, 120, and 150 mL). In the MR‐SIM, additional scans were

Couch corrections determined during localization were applied. A

acquired with a constant rectal volume of 60 mL and varying bladder

point dose measurement was acquired between the prostate and

volumes (90, 150, 250, and 350 mL) ranging from a mostly empty

rectum using an MR‐compatible A12 Exradin ion chamber (Standard

bladder to a mostly full bladder. The ﬁxed rectal and bladder vol-

Imaging Inc., Middleton, WI) and compared to the TPS.

umes of 60 and 250 mL, respectively, were selected as prostate cancer treatments that are ideally simulated/delivered with a mostly
empty rectum and mostly full bladder.19 Organ visibility was qualititatively evaluated for each imaging modality. Rectum and bladder
volumes were delineated on CT‐SIM and MR‐SIM T2W datasets in

3 | RESULTS
3.A | Phantom geometry

MIM Maestro (MIM Software. Inc, Beachwood, OH) to analyze ﬁlling

Table 1 best summarizes the average dimensions of the male pelvis

accuracy, deﬁned as the difference between expected and measured

habitus and pelvic skeleton geometry measured from the 19‐patient

volumes.

cohort. The ﬁnal male pelvis phantom external acrylic casing was
38.1 cm wide (4.3% less than expected) and 23.0 cm tall. The ﬁnal

2.D.3 | Organ interactions

phantom skeletal structure greater trochanter width had the largest
percent difference (11.2%) from the desired values. However, all

Contours were generated for the bladder, rectum, and prostate on

skeletal dimensions were within the range of measurements taken

all MR‐SIM T2W datasets in MIM. Centroid displacements due to

from the patient population data.

CUNNINGHAM

|

ET AL.

269

T A B L E 1 Patient population and ﬁnal phantom pelvic habitus and skeleton dimensions.
Measurement

Patient population dimensions (cm) mean ± SD (range)

Final phantom dimension (cm)

Body width (left–right)

36.5 ± 1.9 (33.6–40.0)

38.1

4.3

Body height (anterior–posterior)

23.0 ± 1.4 (21.2–25.6)

23.0

0

1.6 ± 0.4 (1.0–2.2)

1.6

0

Iliac crest width

25.5 ± 2.1 (22.8–28.8)

27.2

6.4

Femoral head width

22.2 ± 1.3 (20.0–25.5)

23.5

5.7

Greater trochanter width

30.2 ± 1.6 (26.9–34.4)

33.8

11.2

Pelvic depth

14.7 ± 1.0 (12.8–17.0)

14.2

3.5

Pelvic height

20.9 ± 1.4 (17.4–23.4)

20.8

0.5

Sacrum—external Spacing

Percent difference

Values are given as a mean of the prostate patient population (n = 19).
SD, standard deviation.
Percent difference calculated between the mean of the patient population dimensions and ﬁnal phantom dimensions.

3.B | Internal organ kinematics
To quantify internal status changes, bladder ﬁlling data from 10

and MR signal is a suitable substitute material for exterior organ
shells.15 The barbed ﬁtting used to tether the balloon to the catheter
at each end withstood balloon pressure at maximum volume.

human subjects yielded an average bladder volume difference of
87% between empty (81.9 ± 66.9 mL) and full (383.0 ± 346.7 mL)
bladders. Figure 1 shows a 3D rendering of the volumetric bladder

3.C.2 | Bone considerations

and rectum at each time point for a representative case, highlighting

Both mold‐cast pelvises had anthropomorphic shapes, but the clear

the large longitudinal displacement between initial and ﬁnal bladder

urethane pelvis structure did not include femoral heads and was

volumes. Bladder centroids translated 13.2 ± 11.7 mm superiorly,

>12% different than desired in pelvic width and depth. The clear

1.7 ± 7.5 mm anteriorly, and 1.4 ± 4.2 mm laterally (left) over the

pelvis also had a CT number of 60 HU, which is considerably less

cohort. On average, rectum centroids moved 1.7 ± 10.7 mm superi-

than the CT number of cancellous bone (262 HU).20 The blue dyed

orly, 1.2 ± 2.8 mm posteriorly, and 0.2 ± 1.0 mm laterally (left). Fig-

urethane pelvis included femoral heads, was appropriately sized, and

ure 2(a) demonstrates the position and growth of the bladder and

exhibited a CT number closer to that of cancellous bone (213 HU).

rectum over time for three of the subjects who participated in the

Neither pelvis generated a signal in MRI sequences, particularly in

bladder ﬁlling study. Rectal volumes ranged between 30 and 270 mL

the UTE acquisition, and neither approximated cortical bone

(105 ± 65 mL). The results for the width and length of the rectum

(1454 HU).20 Nevertheless, the blue urethane was selected for the

contour as well as the distance from the coccyx to the posterior of

initial phantom build due to its higher CT number.

the rectum are shown in Fig. 2(b). The rectum yielded the largest
increase in width in its center between the initial and ﬁnal time
points, demonstrating that a balloon with a larger length than width,
and with a wide central axis was needed to simulate the rectum. A

3.D | Phantom build
The ﬁnal phantom build is shown Figs. 3(a)–3(c), with average male

coccyx to posterior rectum distance of approximately 5 cm was rec-

pelvic anatomy (height/width = 23.0/38.1 cm). Final material candi-

ommended for rectal balloon placement within the phantom.

dates were as follows: 300‐mL silicone balloons for the bladder
(#BM‐300‐2), and rectum (#BM‐300‐3), and blue dyed urethane

3.C | Phantom materials

(PT8957) for the pelvic structure. Each balloon was tethered at both

3.C.1 | Bladder considerations

ends (axially) by their catheter to the pelvic structure by thin silicone

The silicone and polyisoprene balloons were ﬁlled to a maximum vol-

phantom. The bladder and phantom habitus were ﬁlled with distilled

ume of 250 and 350 mL of distilled water, respectively, without

water doped with 7 and 15 mg/L concentrations of Mn2+ (as

bursting. After one ﬁlling cycle, the polyisoprene balloon showed

MnCl2:4H2O) to achieve a relaxation time of ~900 ms (urine) and

slight deterioration and mechanical changes. The silicone balloon

~300 ms (fat/muscle), respectively. Figure 3(c) highlights the bladder

rubber chord to prevent them from ﬂoating freely throughout the

was more robust during ﬁlling experiments, suggesting that it would

and rectal ﬁlling assembly consisting of two 400‐mL syringes used to

be good for long‐term use within the phantom. The silicone balloon

induce bladder volume changes, a 140‐mL syringe used to ﬁll the

was ﬁlled to >380 mL with little to no air bubbles present. There-

rectum with air, and a 1000‐mL ﬂexible reservoir (Hydrapak, Oak-

fore, the silicone balloon was chosen for use within the phantom as

land, CA) that can be easily removed via quick connect/disconnect

it addressed the concern of deterioration of polyisoprene over time

ﬁttings. The expansion device ﬁlled with the same concentration

with exposure to water and oxygen and was able to achieve the

[15 mg/L of Mn2+ (as MnCl2:4H2O))] of distilled water as the phan-

desired volumes. Additionally, silicone, in terms of electron density

tom habitus was used to account for water displacement caused by

|
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(a)

(c)
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(b)

F I G . 3 . Final phantom build: (a) Sagittal
and (b) coronal view, where the bladder
(Bl) and rectum (R) are represented by the
chosen silicone balloon and the prostate
(P) by a cylindrical silicone sponge. (c) Four
devices (2 × 400 mL syringe, 140‐mL
syringe, and 1000‐mL ﬂexible reservoir)
used to induce bladder and rectal status
changes. (d) Two replaceable endcaps that
allow for the A12 and A26 Exradin MR‐
compatible ion chambers to be inserted
into the phantom and their corresponding
inserts, as well as the ﬁlm cassette.

(d)

varying internal volumes, to decrease internal pressure on the phan-

silicone sponge prostate changed proton density to give MR contrast

tom casing, and also to reduce the amount of air bubbles.

and was visible just beneath the bladder. As expected, the rectal air

A quarter‐inch‐thick polyvinyl alcohol (PVA) open cell sponge

and pelvic bones generated no MR signal, rendering the organ

was inserted between the bladder and rectum to systematically

boundaries indistinguishable from each other. As a result, a quarter‐

tether them together and mimic connective tissue. A silicone sponge

inch‐thick PVA sponge was inserted between the pelvis and rectum

was formed into a cylindrical shape to represent the prostate with a

to introduce a barrier and differing contrast for future imaging stud-

central hole for the 4‐mm‐inner diameter and 7‐mm‐outer diameter

ies. This modiﬁcation was possible due to the modular design of the

silicone rubber tubing bladder catheter (urethra). Three ~10‐cm‐dia-

phantom allowing the phantom interior to be retroﬁtted when

meter removable end caps were added to the exterior of the phan-

needed.

tom to enable access for modular changes such as inserting

The T1W and T2W MR‐SIM images are shown in Figs. 4(c) and

dosimetry equipment and substituting organs while the skeletal

4(d) for rectal volumes of 30, 90, and 150 mL. The PVA sponge suc-

structure is rigidly afﬁxed. Figure 3(d) highlights interchangeable end

cessfully generated a barrier to differentiate between the rectum

caps designed to ﬁt MR‐compatible A12 and A26 Exradin ion cham-

and bones in the T1W and T2W images. The expected T1W con-

bers. Additional dosimetry inserts to accommodate MR‐compatible

trast (darker bladder, brighter background) and T2W contrast

chambers and a 2″ × 2.5″ ﬁlm cassette can also be utilized.

(brighter bladder, darker background) were observed in the MR‐SIM
sequences. Axial views of the T1W and T2W datasets for increasing

3.E | Phantom evaluation
3.E.1 | Simulating bladder and rectal status changes

bladder volumes (90, 150, 250, and 350 mL) are shown in Figs. 5(a)
and 5(b). Delineated bladder volumes differed by a maximum of 11%
(10 mL) from the expected bladder volume of 90 mL. Across all blad-

Sagittal views of the CT‐SIM datasets at inputted rectal volumes (30,

der volumes, an overall difference of 3.1 ± 5.6% (2.5 ± 6.4 mL) was

90, and 150 mL) are shown in Fig. 4(a). The rectum, urethra, bone,

obtained with excellent agreement between expected and measured.

and phantom ﬁlling exhibited contrasts as expected for these tissue
types. However, the bladder was almost indistinguishable from surrounding material and was very difﬁcult to visualize in the CT‐SIM

3.E.2 | Organ interactions

images. Delineated rectal volumes differed by a maximum of 14%

With increasing rectal volumes, both the bladder‐ and prostate‐simu-

(<5 mL) from the expected rectal volume of 30 mL. Overall, a differ-

lated organs translated in the anterior direction as highlighted by the

ence of 3.3 ± 7.0% (0.6 ± 3.8 mL) was obtained over all rectal vol-

MR‐Linac and MR‐SIM sagittal images in Figs. 4(b)–4(d). Negligible

umes with excellent agreement between expected volumes and

centroid shifts (<2.5 mm) were observed in the superior–inferior (S‐I)

delineated volumes.

and L‐R directions. The scatter plot shown in Figs. 6(a) and 6(b) sum-

Figure 4(b) shows the sagittal TrueFISP MR‐Linac images for

marizes the A‐P bladder and prostate centroid displacements for

increasing rectal volumes. In this modality, the bladder was slightly

increasing rectal volumes. The bladder and prostate translated 18.5

darker than background and easier to distinguish. The open cell

and 4.5 mm toward the anterior of the phantom between initial
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bladder

volumes.

Negligible

prostate

centroid
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displacements

(<1.5 mm) were observed in the S‐I and L‐R directions with

(a)

increased bladder size. With increased bladder volumes, minimal rectal displacements were observed in the A‐P direction (<3 mm),
whereas negligible rectum centroid displacements were observed in
the S‐I and L‐R directions (<1.5 mm). However, Fig. 5 highlights that
increasing the bladder volume from 90 to 350 mL resulted in a corresponding rectal compression in the A‐P direction. A 9‐mm
decrease (A‐P) and 6‐mm increase (L‐R) in the rectum width was
observed.

(b)

3.E.3 | Reproducibility tests
Sagittal views of the reproduced 30‐ and 60‐mL rectal volumes in
the MR‐Linac and CT‐SIM are shown in Figs. 7(a) and 7(b), where
similar rectal shapes were observed in each duplicated system. Volume changes observed in each reproduced volume trial are shown in
Fig. 7(c), where smaller rectal volumes were more challenging to

(c)

reproduce due to unpredictable balloon contraction/expansion with
small volumes. The reproduced 30‐mL (n = 3) and 60‐mL (n = 2) rectum volumes exhibited 1.32 ± 0.49 and 0.36 ± 0.46 mm average
vector

centroid

changes

and

5.00 ± 4.14 mL

(~13.8%)

and

1.53 ± 1.06 mL (~2.4%) volume differences, respectively, between
trials. In MR‐SIM, a reproduced bladder volume of 250 mL exhibited
a 1.6 mL (~0.6%) volume change and a 0.70‐mm centroid change
between trials.

(d)

3.F | Dosimetry veriﬁcation
The MR‐SIM, CT‐SIM, and corresponding treatment plan calculated
on the CT‐SIM dataset are shown in Fig. 8. The ion chamber was
visible and contoured in MR‐SIM images. The PTV was expanded in
the posterior direction to ensure the ion chamber did not fall into a
high dose gradient region. The plan met all prescription and organ at
risk dose constraints. The measured point dose between the rectum
F I G . 4 . Increasing rectal volumes: sagittal view for increasing
rectum volumes (30, 90, and 150 mL) for (a) CT‐SIM, (b) MR‐Linac,
(c) T1W MR‐SIM, and (d) T2W MR‐SIM. The bladder (Bl), rectum (R),
prostate (P), and bone (Bo) are labeled in each modality.

and prostate was 212.8 cGy, 1.5% different from the expected
216.0 cGy TPS dose at the chamber location.

4 | DISCUSSION
(30 mL) and ﬁnal (150 mL) rectal volumes, respectively. Strong, negative associations (R2 = 0.94–0.98, P < 0.01) were observed between

With the emergence of MR‐only treatment planning and MR‐IGRT,

increasing rectal volumes and bladder A‐P and prostate A‐P displace-

the need exists to develop an MR‐compatible pelvic phantom that is

ment. Between the initial (30 mL) and ﬁnal (150 mL) rectal volumes,

sophisticated enough to benchmark the uncertainties introduced in

a 6‐mm reduction in bladder width (A‐P) at the centroid location was

these workﬂows. An anthropomorphic and modular end‐to‐end pel-

observed due to the compression induced on the bladder with

vis phantom was designed and evaluated, with the ability to simulate

increased rectal volume.

accurate and reproducible bladder and rectal physiological status

Figures 6(c) and 6(d) best summarize the A‐P centroid displace-

conditions. Additionally, the modularity of the phantom permits the

ments for the rectum and prostate in response to bladder ﬁlling. The

ability to perform dosimetric validation using both point and ﬁlm‐

prostate translated 2.4 mm toward the phantom anterior between

based dosimetry options.

initial and ﬁnal bladder volumes (90 and 350 mL, respectively),

This work introduced several added features to the currently

where a strong, negative correlation (R2 = 0.98, P = 0.0075) was

available MR‐compatible pelvic phantoms. Sun et al. incorporated

observed between prostate displacement (A‐P) and increasing

solid polymethylmethacrylate (PMMA) structures to represent the

272

|

CUNNINGHAM

ET AL.

F I G . 5 . Increasing bladder volumes: axial view for increasing bladder volumes (90, 150, 250, and 350 mL) for (a) T1W MR‐SIM and (b) T2W
MR‐SIM. The bladder (Bl), rectum (R), and bone (Bo) are labeled.

F I G . 6 . Centroid displacements: (a) bladder and (b) prostate anterior–posterior centroid displacement with increasing rectal volume. (c)
Rectum and (d) prostate anterior–posterior centroid displacement with increasing bladder volumes.
rectum and bladder that did not offer the ability to deform.14 As it

little presence of air and did not deteriorate rapidly with continued

is more representative of the pelvic region to simulate anatomical

use. A beneﬁt of this design method is that one can simulate dif-

position variation due to volume variations in the rectum and blad-

ferent physiological status changes at low and high volumes and

der, PETE incorporated both a ﬂuid‐ﬁllable bladder and air‐ﬁllable

measure potential dosimetric and geometric variations that arise

rectum. Previously, Niebuhr et al. and Kadoya et al. incorporated

due to anatomical structure position as a result of intrasession

3D‐printed deformable bladders that accurately represented the

bladder and rectal ﬁlling. The small volume and centroid changes

organs anatomically, but mechanical wear and tear resulted in

obtained from the accuracy and reproducibility studies suggest that

structures needing to be replaced frequently.15 Additionally, at

the robust phantom design allowed for precise and reliable repro-

small volumes, the bladder did not deform well as substantial

duced organ states with little organ displacement at different time

21

The silicone medical bal-

points. The phantom was also able to induce organ shape changes

loons used in PETE to represent the bladder and rectum addressed

and displacements, respectively, with increasing rectal and bladder

these concerns, as the bladder performed well at low volumes with

volumes.

amounts of air remained in the bladder.
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F I G . 7 . Reproduced sagittal volumes: (a)
MR‐Linac 30 mL and (b) CT‐SIM 60 mL
datasets for reproduced rectum trials. (c)
Volume changes for the bladder and
rectum from trials 1 and 2 of duplicated
rectal volumes in each modality, with the
corresponding percent volume changes.
insertion of Gafchromic ﬁlm for planar dose veriﬁcation or A26 small
ion chamber can be explored in future work. Other future work can
include incorporating inserts to include OSLDs or a 3D‐printed hollow shelled deformable prostate surrogate as opposed to the cylindrical silicone prostate. This prostate volume may be ﬁlled with
either a doped agarose gel15 that exhibits similar MR signal generation properties (T1 = 1317 ± 85 ms and T2 = 88 ± 0 ms at 1.5 T)22
as the prostate or a gel with dosimetric properties. Gel dosimetry
has shown promise for measuring 3D dose distributions23 and may
prove useful within the prostate casing.
A major obstacle with MR‐compatible phantoms is simulating
skeletal anatomy with materials that accurately generate tissue
speciﬁc signal in MRI. Sun et al., was able to represent the low MR
signal intensity of the femoral heads by ﬁlling spherical PMMA structures.14 However, they did not incorporate a structure to represent
the rest of the skeletal anatomy. Niebuhr et al. used a 3D‐printed
hollow bone case ﬁlled with a combination of Vaseline and K2HPO4
to accurately represent inner bone.15 This method generated the signal intensity of inner and outer bone in MRI but lacked the attenuation properties of outer bone in CT. More recently, Soliman et al.
used a human skull in a realistic head phantom, which was advantageous as it depicted the properties of cortical bone in UTE
F I G . 8 . Treatment plan: axial and sagittal views of the CT‐SIM,
0.35 T MR‐SIM, and dose for an 11‐ﬁeld IMRT 6XFFF MR‐Linac
treatment plan at the same slice in the phantom. Contours of the
bladder (green), rectum (blue), gross tumor volume (pink), planned
target volume (red), and ion chamber (yellow) are shown. The
chamber is not delineated in the MR‐SIM to highlight its visibility for
localization.

sequences that are difﬁcult to simulate.24 The skeletal anatomy in
PETE was represented by a blue dyed urethane pelvis that was
unable to generate the MRI signal characteristics of human cortical
bone. However, Rai et al. has identiﬁed a 3D printable solid resin
material that has similar signal properties to cortical bone in UTE
MRI sequences.25 This resin material has been successfully used to
replicate skeletal anatomy in other phantoms and may prove useful
in future generations of the PETE phantom. Adoption of this resin

Additionally, previous pelvic phantoms offered limited dosimetry

into a new 3D printed pelvic skeleton structure may improve syn-

options such as optically stimulated luminescent dosimeters (OSLD).

thetic CT generation and dose calculation performed in an MR‐only

Our phantom was designed to enable dosimetric veriﬁcation of

workﬂow.

treatment plans via compatibility with MR‐compatible ion chambers,

Additional limitations exist in the phantom design, including only

with a dosimetric point dose agreement to <1.5% from expected for

considering male anatomy for phantom and organ geometry. Male

an A12 ion chamber. Due to the modular design and endcaps, the

anatomy was simulated as the MR‐only RT is FDA approved or CE
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marked and in clinical use for the treatment of prostate cancer.26,27
While the modular phantom does enable the introduction of 3D
printed organs for female anatomy (uterus, cervix, etc.), as other
deformable phantoms have,21 the current pelvic skeleton geometry
does not accurately represent the average female anatomy. The pelvis structure was modeled after the male pelvis, which is taller and
narrower than the female pelvis, with a 7% difference in width to
height ratios.28 Future extensions of this work include incorporating
a penile bulb and reorganization of internal organs so that the rectum interacts more closely with the prostate.
Despite some of the above limitations, a novel, anthropomorphic,
and modular pelvic phantom with the ability to simulate bladder and
rectal status changes was developed and validated. Potential future
clinical applications of this phantom include the benchmarking of
MR-to-MR deformable image registration algorithms, evaluation of
MR‐based adaptive workﬂows, quantifying distortions in MR images
due to susceptibility effects at air‐tissue interfaces, and evaluating
the electron return effect for MR‐IGRT.

5 | CONCLUSION
A novel end‐to‐end pelvis phantom has been developed to validate
MR‐only and MR‐IGRT workﬂows, with the ability to perform both
dosimetric and geometric evaluations.
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